Respiratory Pathogen Panel (RPP)

Certivia Laboratories provides a rapid response to respiratory pathogen testing for 21 respiratory targets utilizing FDA approved Qiagen QIAstat-Dx Analyzer.

Bacterial

  • Bordetella pertussis

  • Chlamydophila pneumoniae

  • Mycoplasma pneumoniae

Viral

  • Adenovirus

  • Coronavirus 229E

  • Coronavirus HKU1

  • Coronavirus NL63

  • Coronavirus OC43

  • Human Metapneumovirus A/B

  • Influenza A

  • Influenza A subtype H1N1/2009

  • Influenza A subtype H1

  • Influenza A subtype  H3

  • Influenza B

  • Parainfluenza virus 1

  • Parainfluenza virus 2

  • Parainfluenza virus 3

  • Parainfluenza virus4

  • Respiratory Syncytial virus A/B

  • Rhinovirus/Enterovirus

  • SARS-CoV-2 

Testing Details

Methodology                                    

Reverse Transcription PCR (RT-PCR)

Specimen Type                                  

Nasopharyngeal swab

Related Documents